BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1662365)

  • 1. Generation of a large library of point mutations in polyoma middle T antigen.
    Druker BJ; Roberts TM
    Nucleic Acids Res; 1991 Dec; 19(24):6855-61. PubMed ID: 1662365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A completely transformation-defective point mutant of polyomavirus middle T antigen which retains full associated phosphatidylinositol kinase activity.
    Druker BJ; Ling LE; Cohen B; Roberts TM; Schaffhausen BS
    J Virol; 1990 Sep; 64(9):4454-61. PubMed ID: 2166824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyomavirus middle T-antigen NPTY mutants.
    Druker BJ; Sibert L; Roberts TM
    J Virol; 1992 Oct; 66(10):5770-6. PubMed ID: 1326642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant retroviruses that transduce middle T antigen cDNAs derived from polyomavirus mutants: separation of focus formation and soft-agar growth in transformation assays and correlations with kinase activities in vitro.
    Morgan WC; Kaplan DR; Pallas DC; Roberts TM
    J Virol; 1988 Sep; 62(9):3407-14. PubMed ID: 2841493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of p62c-yes with polyomavirus middle T-antigen mutants correlates with transforming ability.
    Kornbluth S; Cheng SH; Markland W; Fukui Y; Hanafusa H
    J Virol; 1990 Apr; 64(4):1584-9. PubMed ID: 1690822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of polyomavirus middle-T-antigen-transformed rat cell variants expressing different levels of pp60c-src.
    Bolen JB; Amini S; DeSeau V; Reddy S; Shalloway D
    J Virol; 1987 Apr; 61(4):1079-85. PubMed ID: 2434664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Middle tumor antigen of polyomavirus transformation-defective mutant NG59 is associated with pp60c-src.
    Bolen JB; Israel MA
    J Virol; 1985 Jan; 53(1):114-9. PubMed ID: 2981329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylinositol metabolism and polyoma-mediated transformation.
    Kaplan DR; Whitman M; Schaffhausen B; Raptis L; Garcea RL; Pallas D; Roberts TM; Cantley L
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3624-8. PubMed ID: 2424008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of pp60c-src protein kinase by herbimycin A in polyomavirus middle tumor antigen-transformed cells.
    Yang YW; Chang YH
    Anticancer Res; 1997; 17(5A):3273-9. PubMed ID: 9413159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformation by viral and cellular oncogenes of a mouse BALB/3T3 cell mutant resistant to transformation by chemical carcinogens.
    Ono M; Yakushinji M; Segawa K; Kuwano M
    Mol Cell Biol; 1988 Oct; 8(10):4190-6. PubMed ID: 3054511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling.
    Denis D; Rouleau C; Schaffhausen BS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27852846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming signals generated by the polyoma virus tumor antigens.
    Raptis L; Marcellus RC; Whitfield JF
    Adv Enzyme Regul; 1990; 30():133-42. PubMed ID: 2169695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of p60fyn with middle tumor antigen in murine polyomavirus-transformed rat cells.
    Horak ID; Kawakami T; Gregory F; Robbins KC; Bolen JB
    J Virol; 1989 May; 63(5):2343-7. PubMed ID: 2539523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitosis-specific phosphorylation of polyomavirus middle-sized tumor antigen and its role during cell transformation.
    Pérez L; Paasinen A; Schnierle B; Käch S; Senften M; Ballmer-Hofer K
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8113-7. PubMed ID: 7690142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyoma middle T antigen or v-src desensitizes human epidermal growth factor receptor function and interference by a monensin-resistant mutation in mouse Balb/3T3 cells.
    Ono M; Nakayama Y; Princler G; Gopas J; Kung HF; Kuwano M
    Exp Cell Res; 1992 Dec; 203(2):456-65. PubMed ID: 1459205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyoma virus small tumor antigen pre-mRNA splicing requires cooperation between two 3' splice sites.
    Ge H; Noble J; Colgan J; Manley JL
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3338-42. PubMed ID: 2159146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of transformation by polyoma virus middle T antigen.
    Kaplan DR; Pallas DC; Morgan W; Schaffhausen B; Roberts TM
    Biochim Biophys Acta; 1989 Feb; 948(3):345-64. PubMed ID: 2465782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmission of the polyoma virus middle T gene as the oncogene of a murine retrovirus.
    Donoghue DJ; Anderson C; Hunter T; Kaplan PL
    Nature; 1984 Apr 19-25; 308(5961):748-50. PubMed ID: 6325917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversion of middle T antigen-transformed Rat-2 cells by Krev-1: implications for the role of p21c-ras in polyomavirus-mediated transformation.
    Jelinek MA; Hassell JA
    Oncogene; 1992 Sep; 7(9):1687-98. PubMed ID: 1380149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine phosphorylation is a signal for the trafficking of pp85, an 85-kDa phosphorylated polypeptide associated with phosphatidylinositol kinase activity.
    Cohen B; Yoakim M; Piwnica-Worms H; Roberts TM; Schaffhausen BS
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4458-62. PubMed ID: 1693771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.